Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
13/08/2025
Novo Nordisk's Executive Vice President Ludovic Ellefson sold stocks and cashed out 3.91 million Danish krone.
Latest
3 m ago
Wisdom Pharmaceutical and Coontai reached a deep strategic cooperation.
4 m ago
An explosion at a dynamite factory in southern Brazil has killed 9 people.
4 m ago
CITIC Securities: Suggest focusing on three types of brain-machine interface companies.
4 m ago
CITIC Securities pointed out that the development of brain-machine interface technology can restore physical function, enhance cognitive abilities, and achieve synergy between humans and machines. In the long term, brain-machine interface technology will drive the common evolution of humans and machines, which will not only change our way of life but also bring about new social and economic structures. With the continuous advancement of technology and the expansion of application scenarios, the potential of brain-machine interfaces will be further unleashed, pushing humanity into a new era of deep integration between humans and machines. It is recommended to pay attention to: 1. Leading companies expected to quickly bring medical-grade products to the market; 2. Companies expected to launch consumer-grade brain-machine products; 3. Companies with key technological accumulation in brain-machine interfaces.
4 m ago
Zhonghui Biotech-B (02627.HK) under its subsidiary Huierkangxin has been selected as the only vaccine on the national medical insurance innovative drug preliminary review list.
See all latest